The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II, open-label, multicenter study to evaluate the safety, efficacy, and pharmacokinetics/pharmacodynamics of αvβ3/5 integrin and neuropilin-1 targeting peptide LSTA1 in patients with metastatic pancreatic ductal adenocarcinoma.
 
Jianming Xu
No Relationships to Disclose
 
Zuoxing Niu
No Relationships to Disclose
 
Yuxian Bai
No Relationships to Disclose
 
Wensheng Qiu
No Relationships to Disclose
 
Jiuwei Cui
No Relationships to Disclose
 
Xiujuan Qu
No Relationships to Disclose
 
Zheng Wu
No Relationships to Disclose
 
Yong Zha
No Relationships to Disclose
 
Tao Zhang
No Relationships to Disclose
 
Wei Cheng
No Relationships to Disclose
 
Cuicui Han
Employment - Qilu Pharmaceutical
 
Meimei Si
Employment - Qilu Pharmaceutical
 
Lingyan Li
Employment - Qilu Pharmaceutical
 
Xiaoyan Kang
Employment - Qilu Pharmaceutical